Subscribe To
HAE / Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why
![Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why](https://cdn.snapi.dev/images/v1/q/x/default14-2113765.jpg)
HAE News
![Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/w/m/transcript4-2140218.jpg)
By Seeking Alpha
November 3, 2023
Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript
Haemonetics Corporation (NYSE:HAE ) Q2 2024 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Olga Guyette – Senior Director more_horizontal
![Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up](https://cdn.snapi.dev/images/v1/a/w/44156-2139459.jpg)
By Zacks Investment Research
November 3, 2023
Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up
The robust volume growth and price benefits in the Plasma business driven by strong momentum in U.S. collections and price benefit Haemonetics' (HAE) more_horizontal
![Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why](https://cdn.snapi.dev/images/v1/q/x/default14-2113765.jpg)
By Zacks Investment Research
October 20, 2023
Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why
Haemonetics (HAE) could produce exceptional returns because of its solid growth attributes. more_horizontal
![Haemonetics (HAE) Moves to Strong Buy: Rationale Behind the Upgrade Haemonetics (HAE) Moves to Strong Buy: Rationale Behind the Upgrade](https://cdn.snapi.dev/images/v1/7/a/default21-2099364.jpg)
By Zacks Investment Research
October 11, 2023
Haemonetics (HAE) Moves to Strong Buy: Rationale Behind the Upgrade
Haemonetics (HAE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy more_horizontal
![Haemonetics (HAE) Announces Agreement to Acquire OpSens Haemonetics (HAE) Announces Agreement to Acquire OpSens](https://cdn.snapi.dev/images/v1/u/d/2848-2099297.jpg)
By Zacks Investment Research
October 11, 2023
Haemonetics (HAE) Announces Agreement to Acquire OpSens
Haemonetics' (HAE) acquisition of OpSens will expand its leadership in the interventional cardiology market. more_horizontal
![Opsens stock soars on takeover deal with Haemonetics Opsens stock soars on takeover deal with Haemonetics](https://cdn.snapi.dev/images/v1/u/r/shutterstock-559819330-65257a7ed114d-2097338.jpg)
By Proactive Investors
October 10, 2023
Opsens stock soars on takeover deal with Haemonetics
Opsens Inc shares surged 47% to $2.84 in midday trading on Tuesday after the cardiology-focused medical device company agreed to be acquired by glob more_horizontal
![Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year? Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year?](https://cdn.snapi.dev/images/v1/x/1/default12-2089849.jpg)
By Zacks Investment Research
October 4, 2023
Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year?
Here is how Haemonetics (HAE) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year. more_horizontal
![HAE vs. SYK: Which Stock Is the Better Value Option? HAE vs. SYK: Which Stock Is the Better Value Option?](https://cdn.snapi.dev/images/v1/q/h/default19-2076698.jpg)
By Zacks Investment Research
September 25, 2023
HAE vs. SYK: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stock more_horizontal